NR3C2 and myocardial infarction: Early studies showed that treatment with MR antagonists post-MI had little or no effect on the progression of infarct-healing but can prevent development of reactive fibrosis in the viable rodent myocardium (Delyani et al., 2001; Mill et al., 2003).